In Brief NCCN creates Quick Guide for patients with Waldenström’s Macroglobulinemia February 10, 2017Vol.43 No.06
Drugs & Targets FDA approves Opdivo for urothelial carcinoma indication February 10, 2017Vol.43 No.06
Drugs & Targets GenomeDx, Astellas work to identify genomic drivers of Xtandi response February 10, 2017Vol.43 No.06
Steve Hahn takes over day to day operations at MD Anderson February 10, 2017Vol.43 No.06By Paul Goldberg
Funding Opportunities SU2C to fund Dream Teams focused on “cancer interception” in pancreas and lungs February 03, 2017Vol.43 No.05
Drugs & Targets MD Anderson, Guardant form partnership to make liquid biopsy standard of care February 03, 2017Vol.43 No.05
Drugs & Targets Addario institute and Scancell form partnership focused on vaccine February 03, 2017Vol.43 No.05